2014
DOI: 10.14218/jcth.2014.00011
|View full text |Cite
|
Sign up to set email alerts
|

Hepatotoxicity Secondary to Chemotherapy

Abstract: The difficult problem faced by multiple generation of practicing physicians is determining the cause of abnormal liver function tests in cancer patients on chemotherapy. Hepatotoxicity from chemotherapy occurs frequently from an unpredictable or idiosyncratic reaction. Despite remarkable advances in our understanding of the mechanisms of action, pharmacodynamics, and interrelationships between the liver and chemotherapy, the underlying etiology of hepatic toxicity for various agents remains unexplained. Here, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
47
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 75 publications
(55 citation statements)
references
References 78 publications
1
47
0
Order By: Relevance
“…These patients whom suffered previously from chemotherapeutic drugs failures are now getting an important result with the reduced progression of cancer as well as increasing the rate of survival (2). Regardless of this significant progression in chemotherapy drugs for many malignant diseases, the hepatotoxicity stays one of the chief side effects and sometimes become a lifethreatening problem (3).…”
Section: Introductionmentioning
confidence: 99%
“…These patients whom suffered previously from chemotherapeutic drugs failures are now getting an important result with the reduced progression of cancer as well as increasing the rate of survival (2). Regardless of this significant progression in chemotherapy drugs for many malignant diseases, the hepatotoxicity stays one of the chief side effects and sometimes become a lifethreatening problem (3).…”
Section: Introductionmentioning
confidence: 99%
“…The severity varies from an asymptomatic elevation of the liver function test, acute liver failure, or progressive fibrosis that culminates in end-stage liver disease. Several antineoplastic drugs, such as etoposide and vincristine, produce liver toxicity [ 40 ].…”
Section: Resultsmentioning
confidence: 99%
“…Although the ratio of neutrophil to lymphocyte in PDA/AM/P-treated group was slightly increased to untreated group in this study, it was 0.34 near the normal range of the ratio. ALT and AST are biochemical parameters for assessing hepatic toxicity 42 . BUN and creatinine have been used as markers of renal toxicity 43 .…”
Section: Discussionmentioning
confidence: 99%